This Weight Loss Drug Cuts Heart Risk
Image: Unsplash
15 May 2024
A recent study suggests that semaglutide, a weight loss injection, may significantly reduce the risk of heart attacks
Image: Unsplash
The study, presented at the European Congress of Obesity, involved over 17,000 adults aged 45 and over with a body mass index over 27
Image: Unsplash
Participants taking semaglutide had a 20% lower risk of cardiovascular-related death compared to those on a placebo
Image: Unsplash
These benefits were observed regardless of the participants' starting weight or the amount of weight they lost
Image: Unsplash
Semaglutide, marketed under names like Wegovy and Ozempic, has been available for weight loss since 2023
Image: X
Professor John Deanfield, the lead author of the study, suggests that semaglutide could be a game changer in cardiovascular treatment
Image: Unsplash
The drug showed promising cardiovascular benefits beyond weight loss, indicating alternative mechanisms at play
Image: Unsplash
Another study introduced Retatrutide, a new weekly injection for weight loss, showing potential for substantial weight loss
Image: Unsplash
Researchers found that retinatrutide could lead to a 24% reduction in body weight over a 48-week period
Image: Unsplash
These findings signal significant advancements in medical treatments for obesity and cardiovascular health
Image: Unsplash
Check More Stories
Image: Reuters
Image: Unsplash
Image: X
ndtv.com